3种用药方案治疗皮肤过敏的最小成本分析  

Cost-minimization Analysis of 3 Therapeutic Regimens for Skin Allergy

作　　者：周红[1] 王欣[1] 韩晓峰[1] 张德江[1] 

机构地区：[1]空军大连航空医学鉴定训练中心,辽宁大连116013

出　　处：《中国药房》2015年第20期2737-2739,共3页China Pharmacy

摘　　要：目的:评价3种用药方案治疗皮肤过敏的经济学效果。方法:将我中心门诊54例皮肤过敏患者按就诊顺序编号随机分为A、B、C组各18例,分别给予钙片+维生素C(Vc)片+马来酸氯苯那敏片(扑尔敏)、钙片+Vc片+氯雷他定片(开瑞坦)、钙片+Vc片+盐酸西替利嗪片(西可韦)治疗,观察各组近期疗效,并进行最小成本分析。结果:A、B、C组的有效率分别为94.44%、88.89%、94.44%,差异无统计学意义(P>0.05);痊愈率分别为55.56%、38.89%、83.33%,差异有统计学意义(P<0.05)。3组成本分别为169.70、195.70、180.40元,A组成本最低。结论:A组方案较经济,但综合比较C组方案较佳。OBJECTIVE： To evaluate the economic effect of 3 therapeutic regimens in the treatment of skin allergy. METHODS： 54 patients with skin allergy in our hospital were randomly divided into A, B, C groups. They were given calcium＋Vc＋Ma- lay bolt chlorpheniramine （Puermin）, calcium＋Vc＋Loratadine tablets （Kairuitan）, calcium＋Vc＋Cetirizine hydrochloride tablets （Xikewei）, respectively. Short-term efficacy was observed, and analyzed with the minimum cost analysis. RESULTS： Effective rates of A, B, C groups were 94.44%, 88.89% and 94.44%, respectively, there was no statistical significance （P〉0.05） ; the cure rates of 3 groups were 55.56%, 38.89% and 83.33%, there was statistical significance （P〈0.05）. The cost were 169.70 yu- an, 195,70 yuan and 180.40 yuan, respectively. The cost of group A was the lowest. CONCLUSIONS： The regimens of A group is economical, but that of group C the best after comprehensive comparison.

关 键 词：最小成本分析 皮肤过敏 马来酸氯苯那敏片 氯雷他定片 盐酸西替利嗪片 

分 类 号：R956[医药卫生—药学] R986